Why Female Hair Loss Is Different

Male androgenetic alopecia produces a predictable receding hairline and crown baldness. Female hair loss rarely follows this pattern. Instead, women typically experience diffuse thinning — hair loss distributed across the entire scalp, most visible at the part line. The hairline usually stays intact. This diffuse pattern makes it harder to notice early and harder to attribute to a specific cause without proper evaluation.

Because multiple causes can produce identical-looking thinning, a thorough workup — including bloodwork — is essential before starting treatment. Treating androgenetic alopecia when the real cause is iron deficiency, for example, will not restore hair growth.

Cause 1: Female Pattern Hair Loss (Androgenetic Alopecia)

The most common cause of hair loss in women is androgenetic alopecia (AGA), affecting roughly 40% of women by age 50. Despite the name "androgenetic," women with AGA often have normal androgen levels — the issue lies in follicular sensitivity to dihydrotestosterone (DHT), a potent androgen metabolite that miniaturizes hair follicles over time.

The Ludwig classification grades female pattern hair loss from I (mild widening at the part) through III (extensive thinning). Diagnosis is typically clinical, supported by a positive family history. Treatment focuses on blocking DHT's effect on follicles (spironolactone, finasteride in post-menopausal women) and stimulating regrowth (minoxidil).

Cause 2: Telogen Effluvium

Telogen effluvium (TE) is the second most common cause of hair loss in women and the most frequently missed. It occurs when a physiological stress pushes a large percentage of hair follicles simultaneously into the resting (telogen) phase — followed by mass shedding 2–4 months later. By the time hair falls out, the triggering event may be long past, making the connection easy to miss.

Common triggers include postpartum hormonal shifts, major surgery, severe illness (including COVID-19), crash dieting or rapid weight loss, and significant psychological stress. TE is usually self-limiting — hair regrows once the trigger resolves — but chronic TE can persist for years if the underlying stressor is ongoing.

Cause 3: Thyroid Dysfunction

Both hypothyroidism and hyperthyroidism can cause hair loss, making thyroid function testing essential in any female hair loss workup. Thyroid hormone regulates the pace of every biological process, including the hair growth cycle. An underactive thyroid slows the cycle; an overactive thyroid accelerates it — both result in excessive shedding.

Critically, thyroid levels must be properly interpreted. Many women have TSH levels in the "normal" range but at the upper end of that range; some clinicians believe optimal TSH for hair health is 1.0–2.5 mIU/L. Free T3 and T4 levels provide additional information that TSH alone can miss.

Cause 4: Iron Deficiency

Iron deficiency — even without frank anemia — is one of the most underappreciated causes of hair loss in women. Ferritin, the storage form of iron, is the relevant marker. Standard lab reference ranges for ferritin are wide (12–150 ng/mL in many labs), but research shows that hair loss often persists when ferritin is below 30 ng/mL and optimal hair growth requires ferritin above 70 ng/mL.

Heavy menstrual periods, vegetarian or vegan diets, and frequent blood donation are major risk factors for low ferritin. Supplementing iron when ferritin is low is safe, inexpensive, and often produces meaningful hair improvement within 4–6 months. Iron levels should always be measured before supplementing, as excess iron is harmful.

Cause 5: PCOS-Related DHT Elevation

Polycystic ovary syndrome affects approximately 10% of women and commonly causes elevated androgens — including testosterone and DHT. In PCOS, DHT-driven follicular miniaturization is the primary mechanism of hair loss. This type of hair loss often appears earlier in life (teens and twenties) and may be accompanied by other signs of androgen excess: acne, hirsutism (excess facial/body hair), and irregular cycles.

Treatment must address both the hormonal root cause (insulin resistance, androgen excess) and the hair follicles directly. Spironolactone is highly effective for PCOS-related hair loss; addressing insulin resistance with metformin or GLP-1 agonists also reduces androgen production over time.

Cause 6: Hormonal Contraceptives

The relationship between birth control and hair loss is nuanced. Pills with higher androgenic progestins (norgestrel, levonorgestrel) can trigger or worsen hair loss in susceptible women. Conversely, pills with anti-androgenic progestins (drospirenone, cyproterone acetate) can actually improve hair loss by reducing DHT activity at the follicle.

Women who notice hair thinning after starting a new contraceptive should discuss a pill switch with their physician. The pill itself is not the enemy — the androgenicity of the progestin component matters enormously. IUDs with low systemic hormone exposure are generally hair-neutral.

Cause 7: Nutritional Deficiencies Beyond Iron

Zinc, biotin, vitamin D, and protein deficiency can all contribute to hair loss. Severe protein restriction — common in very low-calorie diets — directly impairs hair shaft synthesis. Vitamin D deficiency is endemic (estimates suggest 40%+ of Americans are deficient) and emerging research links low vitamin D to both telogen effluvium and alopecia areata.

Biotin deficiency is relatively rare in women who eat a normal diet, making most commercial "biotin for hair" supplements of limited clinical value unless a true deficiency exists. That said, supplementation is low-risk and may help women on restrictive diets.

The Treatment Ladder

Hair Loss Type	Primary Cause	First-Line Treatment	Additional Options
Female Pattern (AGA)	DHT sensitivity	Minoxidil 5% topical or oral	Spironolactone, low-level laser therapy
Telogen Effluvium	Physical/emotional stress	Address trigger; nutritional support	Minoxidil if prolonged
Thyroid-Related	Thyroid dysfunction	Treat underlying thyroid condition	Optimize TSH to 1–2.5
Iron Deficiency	Low ferritin (<30 ng/mL)	Iron supplementation	Dietary optimization
PCOS-Related	Elevated DHT/testosterone	Spironolactone + minoxidil	Metformin, GLP-1 agonists for IR
Contraceptive-Induced	Androgenic progestin	Switch to anti-androgenic pill	Spironolactone during transition
Advanced / Refractory	Multiple / chronic	PRP (platelet-rich plasma)	Hair transplant evaluation

Oral Minoxidil: A Game-Changer for Women

Low-dose oral minoxidil (0.25–1.25 mg daily) has emerged as one of the most effective tools in female hair loss management. At these doses, the systemic side effects seen at higher anti-hypertensive doses are rare, while efficacy is substantial. Multiple studies show oral minoxidil outperforming topical minoxidil in head-to-head comparisons, likely due to better bioavailability and consistency of delivery. It requires a prescription and physician oversight to monitor blood pressure and heart rate — particularly important for women with cardiovascular risk factors.